FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...

MONDAY, Oct. 28, 2024 -- The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide...

THURSDAY, Oct. 24, 2024 -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new...

THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...

FRIDAY, Nov. 1, 2024 -- Yoga can help ease chronic low back pain, even if the classes are conducted online, a new study shows. Guidelines recommend...

FRIDAY, Oct. 25, 2024 -- As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim...

FRIDAY, Nov. 1, 2024 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer...

FRIDAY, Nov. 1, 2024 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer...

Lower back pain is a common issue that affects around 8 out of 10 people at some point in their lives. Researchers are now exploring a potential...